UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.88 +0.25 (+0.32%) GOLD FUTURES
2,393.60 -1.30 (-0.05%) DOW
39,908.00 +349.89 (+0.88%) Bitcoin GBP
52,042.64 +3,463.05 (+7.13%)
The fight against COVID19
23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
TREA analyses over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: US FDA (US Food and Drug Administration), US NIH (US National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history of at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2, among others.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The fight against COVID19 | +1.12% | - | - | - |
| ^GSPC | +1.17% | +5.08% | +29.15% | +5607.69% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 152.67 | +1.29 | +0.85% | 16:00 GMT-4 | 5.37M | 7.52M | 367.43B |
| ABBV | AbbVie Inc. | 163.79 | +2.20 | +1.36% | 16:00 GMT-4 | 5.26M | 5.66M | 289.23B |
| PFE | Pfizer Inc. | 28.82 | +0.44 | +1.55% | 16:01 GMT-4 | 34.60M | 42.74M | 163.66B |
| SNY | Sanofi | 49.01 | -0.49 | -0.99% | 16:00 GMT-4 | 4.25M | 1.98M | 125.81B |
| REGN | Regeneron Pharmaceuticals, Inc. | 978.21 | -6.43 | -0.65% | 16:00 GMT-4 | 590.22k | 453.61k | 106.94B |
| GSK | GlaxoSmithKline plc | 45.7 | +0.04 | +0.09% | 16:00 GMT-4 | 3.77M | 3.15M | 93.50B |
| GILD | Gilead Sciences, Inc. | 67.01 | -0.64 | -0.95% | 16:00 GMT-4 | 7.53M | 7.15M | 83.48B |
| MRNA | Moderna, Inc. | 129.06 | +0.74 | +0.58% | 16:00 GMT-4 | 2.94M | 3.86M | 49.46B |
| TAK | Takeda Pharmaceutical Company Limited | 13.39 | -0.06 | -0.45% | 16:00 GMT-4 | 1.10M | 1.67M | 42.02B |
| BNTX | BioNTech SE | 92.2 | -0.08 | -0.09% | 16:00 GMT-4 | 467.64k | 595.48k | 22.33B |
| NVAX | Novavax, Inc. | 12.9 | -0.58 | -4.30% | 16:00 GMT-4 | 24.39M | 12.19M | 1.90B |
| VIR | Vir Biotechnology, Inc. | 10.02 | -0.06 | -0.60% | 16:00 GMT-4 | 717.88k | 1.00M | 1.36B |
| INO | Inovio Pharmaceuticals, Inc. | 13.07 | +1.65 | +14.45% | 16:00 GMT-4 | 731.54k | 440.23k | 338.60M |
Motley Fool1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
A potentially very lucrative arrangement with a peer doesn't necessarily make the company a buy.
Yahoo Finance UKUK inflation ‘unavoidable’ but Bank of England should revamp forecasting model, says Bernanke
Former chairman of US Federal Reserve tells MPs BoE should fix forecasting errors and update out-of-date processes.
Motley Fool1 No-Brainer Growth Stock to Buy and Hold for 10 Years
This company's potential far outweighs its risks.
Sign in to view your followed lists
© 2024 Yahoo. All rights reserved.